PL408096A1 - Pharmaceutical product with plant extract and the set of pharmaceutical product with plant extract - Google Patents
Pharmaceutical product with plant extract and the set of pharmaceutical product with plant extractInfo
- Publication number
- PL408096A1 PL408096A1 PL408096A PL40809614A PL408096A1 PL 408096 A1 PL408096 A1 PL 408096A1 PL 408096 A PL408096 A PL 408096A PL 40809614 A PL40809614 A PL 40809614A PL 408096 A1 PL408096 A1 PL 408096A1
- Authority
- PL
- Poland
- Prior art keywords
- pharmaceutical product
- plant extract
- extract
- garlic
- alcoholic
- Prior art date
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Wynalazek rozwiązuje problem otrzymania kompozycji farmaceutycznej o stałej postaci dawkowania ekstraktu roślinnego, charakteryzującej się bardzo dogodną drogą podawania doustnego i ustaloną dawką substancji aktywnych, przy zachowaniu właściwości leczniczych. Produkt farmaceutyczny charakteryzuje się tym, że zawiera alkoholowy ekstrakt roślinny, korzystnie alkoholowy ekstrakt czosnku połączony z wodnym roztworem substancji żelującej, korzystnie substancji agar - agar, zawierającej korzystnie środek barwiący, i/lub środek smakowy i/lub środek zapachowy. Zestaw produktu farmaceutycznego z ekstraktem roślinnym charakteryzuje się tym, że w jednym pojemniku znajduje się produkt farmaceutyczny o stałej postaci, zawierający alkoholowy ekstrakt czosnku, przy czym dowolnie wybrany kształt produktu farmaceutycznego odpowiada ściśle określonej ilości alkoholowego ekstraktu czosnku.The invention solves the problem of obtaining a pharmaceutical composition with a solid dosage form of a plant extract, characterized by a very convenient route of oral administration and a fixed dose of active substances, while maintaining therapeutic properties. The pharmaceutical product is characterized in that it comprises an alcoholic plant extract, preferably an alcoholic garlic extract combined with an aqueous solution of a gelling agent, preferably an agar-agar substance, preferably containing a coloring agent and / or a flavoring agent and / or a flavoring agent. A pharmaceutical product kit with a plant extract is characterized in that in one container there is a solid pharmaceutical product containing garlic alcohol extract, where any shape of the pharmaceutical product corresponds to a strictly defined amount of garlic alcohol extract.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL408096A PL408096A1 (en) | 2014-05-02 | 2014-05-02 | Pharmaceutical product with plant extract and the set of pharmaceutical product with plant extract |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL408096A PL408096A1 (en) | 2014-05-02 | 2014-05-02 | Pharmaceutical product with plant extract and the set of pharmaceutical product with plant extract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL408096A1 true PL408096A1 (en) | 2015-11-09 |
Family
ID=54364830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL408096A PL408096A1 (en) | 2014-05-02 | 2014-05-02 | Pharmaceutical product with plant extract and the set of pharmaceutical product with plant extract |
Country Status (1)
| Country | Link |
|---|---|
| PL (1) | PL408096A1 (en) |
-
2014
- 2014-05-02 PL PL408096A patent/PL408096A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021006035A (en) | Stable cannabinoid formulations. | |
| BR112018076601A2 (en) | oral pharmaceutical formulation, methods for treating a patient, and use of a formulation | |
| PH12016500433A1 (en) | Stable fixed dose pharmaceutical composition comprising mometasone and olopatadine | |
| MY191980A (en) | Formulations containing an extract of echinacea and linoleic acid derivatives | |
| PH12015502535A1 (en) | Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes | |
| EA201691918A1 (en) | PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE | |
| CY1124893T1 (en) | MAROPITANTIS MEDICINAL MIXTURE | |
| MA49947A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ANTI-BETA-AMYLOID ANTIBODIES | |
| EA201892842A1 (en) | PHARMACEUTICAL COMPOSITIONS, INCLUDING SAFINAMID | |
| PH12018502139A1 (en) | Phosphaplatin liquid formulations | |
| CY1121708T1 (en) | INDANYL UREA COMPOUNDS WHICH INHIBIT P38 MAP KINASE | |
| PL408096A1 (en) | Pharmaceutical product with plant extract and the set of pharmaceutical product with plant extract | |
| CL2022003426A1 (en) | Levilimab Aqueous Pharmaceutical Composition and Its Use | |
| CO7240380A2 (en) | Pediatric oral liquid compositions containing nepadutant | |
| EA201491995A1 (en) | ORAL MEDICAL FORM | |
| CY1120282T1 (en) | PHARMACEUTICAL COMPOSITION OF SILDENAFIL CITRUS IN THE FORM OF AN ORAL DRIVE FOR USE | |
| EA201891761A1 (en) | NEW BIAROMATIC COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS, THEIR CONTAINING AND THEIR APPLICATION | |
| GEP201606594B (en) | Pharmaceutical composition of sedative and spasmolytic action in soft gelatin capsules (variations) | |
| CL2019002283A1 (en) | Liquid composition containing pradofloxacin. | |
| TR201716207A2 (en) | Pharmaceutical formulations containing vilanterol and umeclidinium. | |
| EA201991190A1 (en) | PHARMACEUTICAL COMPLEX PRODUCT CONTAINING AMLODIPINE, LOZARTAN AND ROSUVASTATIN | |
| TR201714726A1 (en) | Pharmaceutical formulation containing an anticholinergic active ingredient. | |
| PL414785A1 (en) | 3-dodecylsulfanyl-butyric acid to be used as a medicine, preferably to prevent development of insulin immunity and the composition containing 3-dodecylsulfanyl-butyric acid as active substance | |
| TH162586A (en) | Enhanced Stability of Novel Liquid Compositions | |
| TH144575B (en) | Povidone-iodine recipe for spray form |